Novel genomic imbalances in embryonal rhabdomyosarcoma revealed by comparative genomic hybridization and fluorescence in situ hybridization: An intergroup rhabdomyosarcoma study

Julia A. Bridge, Jian Liu, Vines Weibolt, K. Scott Baker, Deborah Perry, Robert Kruger, Stephen Qualman, Frederic Barr, Poul Sorensen, Timothy Triche, Ron Suijkerbuijk

Research output: Contribution to journalArticle

127 Citations (Scopus)

Abstract

A comparative genomic hybridization (CGH) approach provides identification of genomic gains and losses in a tumor specimen in a single experiment. Only II embryonal rhabdomyosarcomas (E-RMS) have previously been subjected to CGH. The underlying genetic events in this histologic subtype are not well defined. In this investigation, 12 E-RMS specimens from 10 patients entered into Intergroup Rhabdomyosarcoma Study (IRS) I-IV and two local patients were analyzed by CGH and fluorescence in situ hybridization (FISH). Gains of chromosomes or chromosomal regions 2 (50%), 7 (42%), 8 (67%), 11 (42%), 12 (58%), 13q21 (33%), and 20 (33%) and losses of 1p35-36.3 (42%), 6 (33%), 9q22 (33%), 14q21-32 (25%), and 17 (25%) were most prominent. Chromosomal regions 1p35-36.3 and 9q22 represent novel regions of loss. Importantly, loss of 9q22 corresponds to the locus of a putative tumor suppressor gene (PTCH), which has been shown to play a role in rhabdomyosarcoma in a mouse model of Gorlin syndrome. Loss of 1p36 corresponds to the locus for PAX7, a paired box containing gene characteristically altered in alveolar rhabdomyosarcoma. Moreover, loss of 1p36 is prominent in another common pediatric soft tissue tumor, neuroblastoma. Gains of 2, 7, 8, 12, and 13 and loss of 14 were seen in the sole prior E-RMS CGH series; thus, these data provide important confirmatory results. In contrast to this previous study, however loss, not gain, of chromosome 17 was observed in the current study. Chromosome 17 loss correlates well with previous descriptions of frequent allelic loss of 17p (TP53) in E-RMS. In summary, CGH and FISH analyses of 12 E-RMS specimens revealed novel genomic imbalances that may be useful in directing further molecular studies for the determination of E-RMS critically involved genes. (C) 2000 Wiley-Liss, Inc.

Original languageEnglish (US)
Pages (from-to)337-344
Number of pages8
JournalGenes Chromosomes and Cancer
Volume27
Issue number4
DOIs
StatePublished - Apr 1 2000

Fingerprint

Embryonal Rhabdomyosarcoma
Comparative Genomic Hybridization
Rhabdomyosarcoma
Fluorescence In Situ Hybridization
In Situ Hybridization
Chromosomes, Human, Pair 17
Alveolar Rhabdomyosarcoma
Basal Cell Nevus Syndrome
Loss of Heterozygosity
Tumor Suppressor Genes
Neuroblastoma
Genes
Neoplasms
Chromosomes
Pediatrics

ASJC Scopus subject areas

  • Genetics
  • Cancer Research

Cite this

Novel genomic imbalances in embryonal rhabdomyosarcoma revealed by comparative genomic hybridization and fluorescence in situ hybridization : An intergroup rhabdomyosarcoma study. / Bridge, Julia A.; Liu, Jian; Weibolt, Vines; Baker, K. Scott; Perry, Deborah; Kruger, Robert; Qualman, Stephen; Barr, Frederic; Sorensen, Poul; Triche, Timothy; Suijkerbuijk, Ron.

In: Genes Chromosomes and Cancer, Vol. 27, No. 4, 01.04.2000, p. 337-344.

Research output: Contribution to journalArticle

Bridge, Julia A. ; Liu, Jian ; Weibolt, Vines ; Baker, K. Scott ; Perry, Deborah ; Kruger, Robert ; Qualman, Stephen ; Barr, Frederic ; Sorensen, Poul ; Triche, Timothy ; Suijkerbuijk, Ron. / Novel genomic imbalances in embryonal rhabdomyosarcoma revealed by comparative genomic hybridization and fluorescence in situ hybridization : An intergroup rhabdomyosarcoma study. In: Genes Chromosomes and Cancer. 2000 ; Vol. 27, No. 4. pp. 337-344.
@article{9804ca4300a94a50bbef570083abd2ef,
title = "Novel genomic imbalances in embryonal rhabdomyosarcoma revealed by comparative genomic hybridization and fluorescence in situ hybridization: An intergroup rhabdomyosarcoma study",
abstract = "A comparative genomic hybridization (CGH) approach provides identification of genomic gains and losses in a tumor specimen in a single experiment. Only II embryonal rhabdomyosarcomas (E-RMS) have previously been subjected to CGH. The underlying genetic events in this histologic subtype are not well defined. In this investigation, 12 E-RMS specimens from 10 patients entered into Intergroup Rhabdomyosarcoma Study (IRS) I-IV and two local patients were analyzed by CGH and fluorescence in situ hybridization (FISH). Gains of chromosomes or chromosomal regions 2 (50{\%}), 7 (42{\%}), 8 (67{\%}), 11 (42{\%}), 12 (58{\%}), 13q21 (33{\%}), and 20 (33{\%}) and losses of 1p35-36.3 (42{\%}), 6 (33{\%}), 9q22 (33{\%}), 14q21-32 (25{\%}), and 17 (25{\%}) were most prominent. Chromosomal regions 1p35-36.3 and 9q22 represent novel regions of loss. Importantly, loss of 9q22 corresponds to the locus of a putative tumor suppressor gene (PTCH), which has been shown to play a role in rhabdomyosarcoma in a mouse model of Gorlin syndrome. Loss of 1p36 corresponds to the locus for PAX7, a paired box containing gene characteristically altered in alveolar rhabdomyosarcoma. Moreover, loss of 1p36 is prominent in another common pediatric soft tissue tumor, neuroblastoma. Gains of 2, 7, 8, 12, and 13 and loss of 14 were seen in the sole prior E-RMS CGH series; thus, these data provide important confirmatory results. In contrast to this previous study, however loss, not gain, of chromosome 17 was observed in the current study. Chromosome 17 loss correlates well with previous descriptions of frequent allelic loss of 17p (TP53) in E-RMS. In summary, CGH and FISH analyses of 12 E-RMS specimens revealed novel genomic imbalances that may be useful in directing further molecular studies for the determination of E-RMS critically involved genes. (C) 2000 Wiley-Liss, Inc.",
author = "Bridge, {Julia A.} and Jian Liu and Vines Weibolt and Baker, {K. Scott} and Deborah Perry and Robert Kruger and Stephen Qualman and Frederic Barr and Poul Sorensen and Timothy Triche and Ron Suijkerbuijk",
year = "2000",
month = "4",
day = "1",
doi = "10.1002/(SICI)1098-2264(200004)27:4<337::AID-GCC1>3.0.CO;2-1",
language = "English (US)",
volume = "27",
pages = "337--344",
journal = "Genes Chromosomes and Cancer",
issn = "1045-2257",
publisher = "Wiley-Liss Inc.",
number = "4",

}

TY - JOUR

T1 - Novel genomic imbalances in embryonal rhabdomyosarcoma revealed by comparative genomic hybridization and fluorescence in situ hybridization

T2 - An intergroup rhabdomyosarcoma study

AU - Bridge, Julia A.

AU - Liu, Jian

AU - Weibolt, Vines

AU - Baker, K. Scott

AU - Perry, Deborah

AU - Kruger, Robert

AU - Qualman, Stephen

AU - Barr, Frederic

AU - Sorensen, Poul

AU - Triche, Timothy

AU - Suijkerbuijk, Ron

PY - 2000/4/1

Y1 - 2000/4/1

N2 - A comparative genomic hybridization (CGH) approach provides identification of genomic gains and losses in a tumor specimen in a single experiment. Only II embryonal rhabdomyosarcomas (E-RMS) have previously been subjected to CGH. The underlying genetic events in this histologic subtype are not well defined. In this investigation, 12 E-RMS specimens from 10 patients entered into Intergroup Rhabdomyosarcoma Study (IRS) I-IV and two local patients were analyzed by CGH and fluorescence in situ hybridization (FISH). Gains of chromosomes or chromosomal regions 2 (50%), 7 (42%), 8 (67%), 11 (42%), 12 (58%), 13q21 (33%), and 20 (33%) and losses of 1p35-36.3 (42%), 6 (33%), 9q22 (33%), 14q21-32 (25%), and 17 (25%) were most prominent. Chromosomal regions 1p35-36.3 and 9q22 represent novel regions of loss. Importantly, loss of 9q22 corresponds to the locus of a putative tumor suppressor gene (PTCH), which has been shown to play a role in rhabdomyosarcoma in a mouse model of Gorlin syndrome. Loss of 1p36 corresponds to the locus for PAX7, a paired box containing gene characteristically altered in alveolar rhabdomyosarcoma. Moreover, loss of 1p36 is prominent in another common pediatric soft tissue tumor, neuroblastoma. Gains of 2, 7, 8, 12, and 13 and loss of 14 were seen in the sole prior E-RMS CGH series; thus, these data provide important confirmatory results. In contrast to this previous study, however loss, not gain, of chromosome 17 was observed in the current study. Chromosome 17 loss correlates well with previous descriptions of frequent allelic loss of 17p (TP53) in E-RMS. In summary, CGH and FISH analyses of 12 E-RMS specimens revealed novel genomic imbalances that may be useful in directing further molecular studies for the determination of E-RMS critically involved genes. (C) 2000 Wiley-Liss, Inc.

AB - A comparative genomic hybridization (CGH) approach provides identification of genomic gains and losses in a tumor specimen in a single experiment. Only II embryonal rhabdomyosarcomas (E-RMS) have previously been subjected to CGH. The underlying genetic events in this histologic subtype are not well defined. In this investigation, 12 E-RMS specimens from 10 patients entered into Intergroup Rhabdomyosarcoma Study (IRS) I-IV and two local patients were analyzed by CGH and fluorescence in situ hybridization (FISH). Gains of chromosomes or chromosomal regions 2 (50%), 7 (42%), 8 (67%), 11 (42%), 12 (58%), 13q21 (33%), and 20 (33%) and losses of 1p35-36.3 (42%), 6 (33%), 9q22 (33%), 14q21-32 (25%), and 17 (25%) were most prominent. Chromosomal regions 1p35-36.3 and 9q22 represent novel regions of loss. Importantly, loss of 9q22 corresponds to the locus of a putative tumor suppressor gene (PTCH), which has been shown to play a role in rhabdomyosarcoma in a mouse model of Gorlin syndrome. Loss of 1p36 corresponds to the locus for PAX7, a paired box containing gene characteristically altered in alveolar rhabdomyosarcoma. Moreover, loss of 1p36 is prominent in another common pediatric soft tissue tumor, neuroblastoma. Gains of 2, 7, 8, 12, and 13 and loss of 14 were seen in the sole prior E-RMS CGH series; thus, these data provide important confirmatory results. In contrast to this previous study, however loss, not gain, of chromosome 17 was observed in the current study. Chromosome 17 loss correlates well with previous descriptions of frequent allelic loss of 17p (TP53) in E-RMS. In summary, CGH and FISH analyses of 12 E-RMS specimens revealed novel genomic imbalances that may be useful in directing further molecular studies for the determination of E-RMS critically involved genes. (C) 2000 Wiley-Liss, Inc.

UR - http://www.scopus.com/inward/record.url?scp=0034088133&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034088133&partnerID=8YFLogxK

U2 - 10.1002/(SICI)1098-2264(200004)27:4<337::AID-GCC1>3.0.CO;2-1

DO - 10.1002/(SICI)1098-2264(200004)27:4<337::AID-GCC1>3.0.CO;2-1

M3 - Article

C2 - 10719362

AN - SCOPUS:0034088133

VL - 27

SP - 337

EP - 344

JO - Genes Chromosomes and Cancer

JF - Genes Chromosomes and Cancer

SN - 1045-2257

IS - 4

ER -